Integral Diagnostics Limited (ASX: IDX)
Australia
· Delayed Price · Currency is AUD 2.900
-0.060 (-2.03%)
Nov 21, 2024, 4:10 PM AEST
Integral Diagnostics Revenue
In the fiscal year ending June 30, 2024, Integral Diagnostics had annual revenue of 469.70M AUD with 6.56% growth. Integral Diagnostics had revenue of 238.44M in the half year ending June 30, 2024, with 32.91% growth.
Revenue
469.70M
Revenue Growth
+6.56%
P/S Ratio
1.44
Revenue / Employee
237.58K
Employees
1,977
Market Cap
678.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 469.70M | 28.94M | 6.56% |
| Jun 30, 2023 | 440.76M | 79.83M | 22.12% |
| Jun 30, 2022 | 360.93M | 10.23M | 2.92% |
| Jun 30, 2021 | 350.70M | 75.13M | 27.26% |
| Jun 30, 2020 | 275.57M | 43.17M | 18.58% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.60B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Ramsay Health Care Limited | 16.66B |
| Telix Pharmaceuticals Limited | 645.68M |
Integral Diagnostics News
- 2 months ago - Integral Diagnostics Ltd (ASX:IDX) Q2 2024 Earnings Call Transcript Highlights: Solid Revenue ... - GuruFocus
- 3 months ago - Integral Diagnostics Ltd (ASX:IDX) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue ... - GuruFocus
- 3 months ago - Full Year 2024 Integral Diagnostics Ltd Earnings Call Transcript - GuruFocus